The latest biotech news

News and Trends 20 Mar 2020

Themis and Institut Pasteur Join Coronavirus Vaccine Hunt

The Austrian biotech Themis — specializing in vaccines for infectious and insect-borne diseases — has jumped on the coronavirus vaccine bandwagon along with the Institut Pasteur and other international partners. The collaboration will be led by the Parisian Institut Pasteur, whose vaccine technology — in this case modifying a measles virus vector to carry coronavirus […]

March 20, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 19 Mar 2020

Labiotech.eu’s Coverage of the Covid-19 Coronavirus

Like many others, the biopharma industry has been shaken by the rapid rise of the coronavirus outbreak. But unlike any other industry, biopharma can solve the growing threat through science and innovation. Our journalists are working hard to deliver as much information as possible on the current crisis. If quality information and independent journalism also […]

March 19, 2020 - 13 minutesmins - By Joachim Eeckhout

News and Trends 18 Mar 2020

OncoOne Raises €13M Series A to Develop First-in-Class Cancer Treatments

Austrian startup OncoOne has closed its first round of venture capital funding after raising €13M to investigate a new treatment target against solid tumor cancers. Investment in the Series A funding included public grants from the Austrian Research Promotion Agency and the promotional bank of the Austrian federal government, the Austria Wirtschaftsservice Gesellschaft, along with […]

March 18, 2020 - 2 minutesmins - By Anita Chakraverty

News and Trends 17 Mar 2020

CureVac Receives €80M from EU to Fund Coronavirus Vaccine Amid US Dispute

The German biotech CureVac — which is developing an mRNA vaccine against coronavirus — has been granted up to €80M by the European Commission, shortly after a dispute erupted over an alleged acquisition offer from the US. The money was awarded to help CureVac quickly scale up the production of its candidate Covid-19 vaccine. It […]

March 17, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 16 Mar 2020

Coronavirus Delays Sensorion’s Hearing Loss Phase II Trial

The French company Sensorion has been forced to delay a phase II trial in people with hearing loss due to slow patient recruitment amid the current coronavirus disease (Covid-19) pandemic. The clinical trial is designed to test Sensorion’s lead candidate drug in people with sudden sensorineural hearing loss, a rare disorder where the patient can […]

March 16, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 13 Mar 2020

Immune Marker in Blood May Predict Kidney Transplant Rejection Risk

French researchers have found that the levels of certain immune cells in the blood of kidney transplant recipients may predict their future risk for transplant rejection. At present, kidney transplantation is the best treatment for people with end-stage renal disease but introducing a ‘foreign’ organ into someone’s body comes with the risk of rejection by […]

March 13, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 12 Mar 2020

Gedea Biotech’s Bacterial Vaginosis Tablet Proves As Good as Antibiotics

An antibiotic-free vaginal tablet developed by the Swedish company Gedea Biotech has cured 82% of women of the common vaginal infection bacterial vaginosis in a 24-patient clinical trial. Bacterial vaginosis occurs when the normal vaginal microflora — characterized by a high proportion of bacteria from the genus Lactobacillus — become unbalanced with an overgrowth of […]

March 12, 2020 - 3 minutesmins - By Laura Cowen

multiple sclerosis neuron sheath medday Pharma

News and Trends 11 Mar 2020

Phase III Fail for MedDay’s Multiple Sclerosis Treatment

A drug developed by the French company MedDay Pharmaceuticals has failed to treat progressive forms of multiple sclerosis in a phase III trial. The 642 patients recruited into the trial received either a placebo or a high dose of pharmaceutical-grade Biotin, also known as vitamin B₇. The patients had various forms of the autoimmune condition […]

March 11, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 11 Mar 2020

Update: Carmat’s Artificial Heart Reaches Two Year Milestone

Update (11/03/2020): In a record first, Carmat announced today that one patient in its artificial heart trial has had the device implanted for 2 years. “Passing a two-year period of individual functioning is very encouraging, and confirms the capacity of our device to provide long-term support, which is one of our two key objectives along […]

March 11, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 10 Mar 2020

LSP Raises €528M in Largest European Life Sciences Investment Fund

Healthcare investor Life Sciences Partners has closed the largest ever European venture capital fund dedicated to new medicines and technologies after raising €528M. LSP 6, the company’s largest private equity fund to date, attracted significantly more than the original €396M target from a diverse investor group that included governments and the EU-supported European Investment Fund. […]

March 10, 2020 - 2 minutesmins - By External Contributor

News and Trends 5 Mar 2020

Drug Development Costs Lower Than Pharma Companies Claim

A team of UK and Belgian scientists has reported that drug companies spend up to €1.3B less on drug development than previously suggested, which raises questions about high drug prices set by some biotech and pharma companies. The study, published in the journal JAMA, took publicly available data from pharma company financial reports with the […]

March 5, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 4 Mar 2020

Immunocore Raises €117M to Develop Immunotherapies for Cancer and Hepatitis B

UK biotech Immunocore has raised €116.7M in Series B funding to develop drugs that harness the body’s immune cells to fight cancer, viral infections, and autoimmune diseases. This latest funding round for the company, which specializes in redirecting and activating T-cells, includes an international group of new investors led by the US private equity firm […]

March 4, 2020 - 2 minutesmins - By External Contributor

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Themis and Institut Pasteur Join Coronavirus Vaccine Hunt

Labiotech.eu’s Coverage of the Covid-19 Coronavirus

OncoOne Raises €13M Series A to Develop First-in-Class Cancer Treatments

CureVac Receives €80M from EU to Fund Coronavirus Vaccine Amid US Dispute

Coronavirus Delays Sensorion’s Hearing Loss Phase II Trial

Immune Marker in Blood May Predict Kidney Transplant Rejection Risk

Gedea Biotech’s Bacterial Vaginosis Tablet Proves As Good as Antibiotics

Phase III Fail for MedDay’s Multiple Sclerosis Treatment

Update: Carmat’s Artificial Heart Reaches Two Year Milestone

LSP Raises €528M in Largest European Life Sciences Investment Fund

Drug Development Costs Lower Than Pharma Companies Claim

Immunocore Raises €117M to Develop Immunotherapies for Cancer and Hepatitis B

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!